Dopamine d1 receptor agonist and d2 receptor antagonist effects of the natural product (-)-stepholidine: Molecular Modeling and dynamics Simulations
文献类型:期刊论文
作者 | Fu, Wei; Shen, Jianhua![]() ![]() ![]() ![]() ![]() ![]() ![]() |
刊名 | BIOPHYSICAL JOURNAL
![]() |
出版日期 | 2007-09 |
卷号 | 93期号:5页码:1431-1441 |
ISSN号 | 0006-3495 |
DOI | 10.1529/biophysj.106.088500 |
文献子类 | Article |
英文摘要 | (-)-Stepholidine (SPD), an active ingredient of the Chinese herb Stephania, is the first compound found to have dual function as a dopamine receptor D1 agonist and D2 antagonist. Insights into dynamical behaviors of D1 and D2 receptors and their interaction modes with SPD are crucial in understanding the structural and functional characteristics of dopamine receptors. In this study a computational approach, integrating protein structure prediction, automated molecular docking, and molecular dynamics simulations were employed to investigate the dual action mechanism of SPD on the D1 and D2 receptors, with the eventual aim to develop new drugs for treating diseases affecting the central nervous system such as schizophrenia. The dynamics simulations revealed the surface features of the electrostatic potentials and the conformational "open-closed'' process of the binding entrances of two dopamine receptors. Potential binding conformations of D1 and D2 receptors were obtained, and the D1-SPD and D2-SPD complexes were generated, which are in good agreement with most of experimental data. The D1-SPD structure shows that the K-167_EL-2-E-302_EL-3 (EL-2: extracellular loop 2; EL-3: extracellular loop 3) salt bridge plays an important role for both the conformational change of the extracellular domain and the binding of SPD. Based on our modeling and simulations, we proposed a mechanism of the dual action of SPD and a subsequent signal transduction model. Further mutagenesis and biophysical experiments are needed to test and improve our proposed dual action mechanism of SPD and signal transduction model. |
WOS关键词 | PROTEIN-COUPLED RECEPTORS ; BINDING-SITE CREVICE ; RHODOPSIN ; ACTIVATION ; RESIDUES ; TETRAHYDROPROTOBERBERINES ; PREDICTION ; SUBTYPES ; MUTATION ; BILAYER |
WOS研究方向 | Biophysics |
语种 | 英语 |
WOS记录号 | WOS:000248722200004 |
出版者 | CELL PRESS |
源URL | [http://119.78.100.183/handle/2S10ELR8/273157] ![]() |
专题 | 药物发现与设计中心 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
通讯作者 | Jiang, Hualiang |
作者单位 | 1.Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci,State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China 3.Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 200032, Peoples R China 4.E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China |
推荐引用方式 GB/T 7714 | Fu, Wei,Shen, Jianhua,Luo, Xiaomin,et al. Dopamine d1 receptor agonist and d2 receptor antagonist effects of the natural product (-)-stepholidine: Molecular Modeling and dynamics Simulations[J]. BIOPHYSICAL JOURNAL,2007,93(5):1431-1441. |
APA | Fu, Wei.,Shen, Jianhua.,Luo, Xiaomin.,Zhu, Weiliang.,Cheng, Jiagao.,...&Jiang, Hualiang.(2007).Dopamine d1 receptor agonist and d2 receptor antagonist effects of the natural product (-)-stepholidine: Molecular Modeling and dynamics Simulations.BIOPHYSICAL JOURNAL,93(5),1431-1441. |
MLA | Fu, Wei,et al."Dopamine d1 receptor agonist and d2 receptor antagonist effects of the natural product (-)-stepholidine: Molecular Modeling and dynamics Simulations".BIOPHYSICAL JOURNAL 93.5(2007):1431-1441. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。